Progesterone caproate injections have been used to reduce the likelihood of premature births in at-risk pregnant women for years. Up until now, the drug was custom-compounded by wholesale and specialist pharmacies, legally, but without federal approval. These injections cost between $5 and $15 a dose and were regularly reimbursed by insurance companies and Medicaid.
Last month, the FDA announced
their approval of a commercially produced version of the compound, to be marketed under the brand name Makena by a company called KV Pharmaceuticals.
No stranger to controversy and trouble, KV barely survived a rash round of
layoffs and wrongful termination lawsuits. Their former chief executive
now faces criminal charges surrounding the company's failure to notify the FDA that they were producing oversized morphine tablets.
(He could also do for a shave, it appears.)
Now, KV has announced that the new drug will be available at a cost of
$1,500 per dose,
bringing the total pregnancy term cost of treatment to $25,000-$30,000, from its former cost of $250-$300, a
100-fold increase—but it gets worse...
[more inside]
posted by disillusioned
on Mar 9, 2011 -
63 comments